[BLOG] Dr. Kurtzer speaks on ‘Medical Marijuana and the Workplace

The use of medical marijuana is expected to increase dramatically in the near future. It is up to Canadian companies to educate themselves and prepare for the impact of cannabis in the workplace.

Dr. Barry Kurtzer, a physician with more than thirty years of experience providing occupational health programs to employers, is recognized as one of Canada’s leading medical experts on the impact of substance use on workplace safety. Dr. Kurtzer helps to educate employers and address the increasingly complex workplace problems created by Canada’s evolving medical marijuana industry.

[BLOG] Zika Virus: Should it be a Concern for Canadian Employers?

As the Zika virus continues to remain a hot topic in the media, DriverCheck clients have expressed concerns for their employees who have, or who will be, travelling for work or on vacation to impacted areas. In this post, we offer advice on how to handle the risks and provide tips on how to prevent infection.

Though the World Health Organization declared the Zika virus a public health emergency last month, there have been very few cases reported in Canada to date. The Public Health Agency of Canada recently confirmed travel-related cases of Zika virus from Central and South America, and from the Caribbean.

DriverCheck Featured in Canadian HR Reporter’s “Medical Marijuana in the Workplace”

DriverCheck’s Medical Director and Chief Medical Review Officer Dr. Barry Kurtzer was recently featured in a Canadian HR Reporter story on medical marijuana in the workplace. With medical marijuana use expected to increase substantially over the next decade, this story examines the new federal regulations around medical marijuana and outlines best practices for employers dealing with employees in safety sensitive positions who have authorization to use marijuana for medical purposes.

DriverCheck to take part in development of global alcohol and drug testing guidelines

The Drug & Alcohol Testing Industry Association (DATIA) and the oil and gas industry are developing global guidelines for contractor drug and alcohol testing programs and DriverCheck has been asked to participate in the process.

“It will be our role to provide input from a Medical Review Officer perspective,” says Dr. Barry Kurtzer, DriverCheck’s Medical Director and Chief Medical Review Officer.

DriverCheck Provides Input on Proposed Drug and Alcohol Testing Clearinghouse

We are pleased to announce that DriverCheck has provided the U.S. Federal Motor Carrier Safety Administration (FMCSA) with an official comment on its proposed rule to establish a drug and alcohol testing clearinghouse.

The proposed clearinghouse is a database under the FMCSA’s administration that will contain controlled substances (drug) and alcohol test result information for the holders of commercial driver’s licenses who are subject to DOT regulated testing.

Arbitration board upholds union position on random testing, in current form

The majority of a 3-member arbitration board in Alberta has ruled a random testing standard for unionized Suncor employees in safety sensitive at its operations in the Regional Municipality of Wood Buffalo (RMWB) “in its present form” is unreasonable. In the ruling, board chair Tom Hodges says Suncor didn’t have enough evidence to prove there is a “significant” alcohol or drug problem within its bargaining unit, or a legitimate safety risk to warrant such a program.

Survey Finds Employers are Preparing for Random Testing Decision

A recent DriverCheck survey has found many employers in the Oil Sands are preparing for a decision expected soon in an outstanding arbitration case on random alcohol and drug testing in Alberta.

In a poll of about 400 DriverCheck clients operating in Alberta, approximately 44 percent of respondents identifying themselves as owner companies say they intend to implement a random testing program in the future, with over half of those companies planning to do so within 3 months to a year.

New Initial Screening Laboratory Opens in Edmonton

A newly certified testing facility in Edmonton could potentially improve DriverCheck’s turnaround times on negative lab-based test results for our clients in Alberta.

Gamma-Dynacare, DriverCheck’s designated drug testing laboratory, received certification this month from the U.S. Department of Health and Human Services (HHS) to provide toxicology screening services at its laboratory in Edmonton, and the laboratory is now listed on the U.S. Federal Register as an HHS-Certified Instrumented Initial Testing Facility.

FMCSA will go through formal rulemaking process to make sleep apnea recommendations mandatory

U.S. President Barack Obama has signed a bill that will require a formal rulemaking process be followed in order for sleep apnea screening to become mandatory for American commercial vehicle drivers. The bill was prompted by the U.S. trucking industry’s fears that the Federal Motor Carrier Safety Administration would issue a guidance rather than go through an extensive formal rulemaking process.

DriverCheck extends a thank you to Canada’s truck drivers

In recognition of National Trucking Week, DriverCheck is thanking Canada’s drivers and their employers for their significant contribution to our country.

With your drivers at the wheel, international trade is rolling. The most recently published statistics show that our country’s carriers transported about 225 billion tonne-kilometres of freight in 2011. That accounts for over half of all trade between Canada and the U.S. and 43 percent of all trade between Canada and the world.

DriverCheck’s designated laboratory expands

A new testing facility planned for Edmonton, Alberta in the fall of 2012 has the potential to improve turnaround times on lab-based tests for DriverCheck clients in the region.

Gamma-Dynacare Medical Laboratories says the facility will provide toxicology screening services to the oil and gas sector and other industries in Western Canada. However, the new laboratory does not currently offer confirmation testing services. Confirmation tests will continue to be sent to DriverCheck’s designated laboratory in London, Ontario.